Advisor Group Inc. grew its holdings in shares of Theralase Technologies Inc. (NASDAQ:TLT) by 13.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 76,612 shares of the company’s stock after purchasing an additional 8,884 shares during the period. Advisor Group Inc. owned approximately 0.12% of Theralase Technologies worth $9,558,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Almanack Investment Partners LLC. raised its stake in Theralase Technologies by 1.9% in the 2nd quarter. Almanack Investment Partners LLC. now owns 1,321 shares of the company’s stock worth $165,000 after acquiring an additional 25 shares during the last quarter. CI Global Investments Inc. purchased a new position in Theralase Technologies in the 2nd quarter worth $167,000. IndexIQ Advisors LLC raised its stake in Theralase Technologies by 42.1% in the 2nd quarter. IndexIQ Advisors LLC now owns 1,360 shares of the company’s stock worth $170,000 after acquiring an additional 403 shares during the last quarter. FNY Partners Fund LP raised its stake in Theralase Technologies by 14,430.0% in the 2nd quarter. FNY Partners Fund LP now owns 1,433 shares of the company’s stock worth $179,000 after acquiring an additional 1,443 shares during the last quarter. Finally, Advisors Preferred LLC purchased a new position in Theralase Technologies in the 2nd quarter worth $199,000.

Shares of Theralase Technologies Inc. (TLT) traded down $1.90 during mid-day trading on Monday, reaching $124.10. The company had a trading volume of 11,980,900 shares, compared to its average volume of 8,343,837. Theralase Technologies Inc. has a one year low of $116.49 and a one year high of $129.57.

The company also recently announced a monthly dividend, which was paid on Tuesday, November 7th. Investors of record on Thursday, November 2nd were paid a $0.2631 dividend. This is a positive change from Theralase Technologies’s previous monthly dividend of $0.25. The ex-dividend date was Wednesday, November 1st. This represents a $3.16 dividend on an annualized basis and a yield of 2.54%. Theralase Technologies’s dividend payout ratio (DPR) is 17.16%.

COPYRIGHT VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/13/advisor-group-inc-has-9-56-million-stake-in-theralase-technologies-inc-tlt.html.

Theralase Technologies Profile

iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years.

Want to see what other hedge funds are holding TLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Theralase Technologies Inc. (NASDAQ:TLT).

Institutional Ownership by Quarter for Theralase Technologies (NASDAQ:TLT)

Receive News & Stock Ratings for Theralase Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies Inc. and related stocks with our FREE daily email newsletter.